| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| DOUGLAS H WILT ACCOUNTING | 900 | 900 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000 SHARES - SALIX PHARMACEUTICALS | 2001-03 | Donated | 2011-03 | 67,002 | 17,954 | Cost | 49,048 | |||
| 1500 SHARES - SALIX PHARMACEUTICALS | 2011-03 | Donated | 2011-09 | 42,708 | 13,466 | Cost | 29,242 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 54,500 SHS SALIX PHARMACEUTICALS, INC. | 489,255 | 2,607,825 |
| 250 SHS ALCOA INC. | 9,535 | 2,162 |
| 260 SHS MANITOWOC CO., INC. | 9,636 | 2,389 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| OFFICE EXPENSE | 27 | 27 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| FEDERAL REFUND | 3 |